ECAE hosts third edition of the Universities Collaboration Forum
The college showcased its leadership in driving innovation in ECD, presenting research-driven practices that reflect its commitment to integrating theory and practice. Faculty members delivered interactive presentations, including a demonstration of the 'Interactive Play Lab', the 'Conceptual PlayWorld in Action' session, and a panel discussion titled 'Transforming the Early Childhood Workplace', where. The panelists shared key findings from an ECA-funded ECAE research project, which explores ways to improve the ECD work environment and promote game-based learning strategies. These efforts reflect ECAE's broader goal of supporting national capacity building in early childhood education and promoting the role of academic institutions in advancing evidence-based development in the sector.
The forum aims to encourage joint initiatives by ECA and universities to support the development of ECA-aligned curricula and create an inclusive, high-quality ECD system in partnership with the higher education sector. It also promotes the use of research and data to inform evidence-based policy, strengthen professional development pathways, and build the skills of the ECD workforce.
In her opening remarks, Dr. May Laith Al Taee, Vice Chancellor of ECAE, emphasized the vital role of academic institutions in supporting national efforts to empower and upskill the ECD workforce. 'Early childhood professionals play a critical role in realizing our leadership's vision for creating inclusive and holistic environments that support the healthy and integrated growth of children in our communities,' she noted. 'Through our collaboration with ECA and academic institutions, we work to translate research insights into tangible practices that positively impact children's lives and strengthen the capacity of ECD professionals to lead with excellence and purpose.'
Dr. Hessa Al Kaabi, Executive Director of the Special Projects and Partnerships Sector at ECA, said: 'As part of our commitment to advancing the early childhood development sector in Abu Dhabi, we collaborate with partners across sectors, particularly higher education and research institutions, to generate evidence-based studies that enhance the capabilities of ECD professionals and promote child sustainable development. These research findings are critical resources that empower caregivers and educators, enabling data-driven decision-making in shaping early childhood policies and practices.'
The forum also featured academic success stories, such as Al Ain University's development of early childhood education offerings and United Arab Emirates University's introduction of an elective course on ECD within its general education program for students across disciplines. ECA also presented a series of projects and initiatives aimed at improving early childhood outcomes in Abu Dhabi. The forum drew strong participation from academic institutions, education experts, researchers, and policymakers.
This ongoing collaboration among ECAE, ECA, and academic partners highlights the value of aligning government policy with research to create a sustainable, inclusive, and supportive educational environment for future generations in Abu Dhabi.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
5 minutes ago
- Zawya
Egypt signs vaccine production agreement with UAE's Al Qalaa, China's Red Flag
Egypt's Holding Company for Biological Products and Vaccines (VACSERA) has signed a memorandum of understanding (MoU) with UAE-based Al Qalaa Investments and China's Red Flag to expand its capacity in human and veterinary vaccine production and develop plasma-derived therapies, the Ministry of Health announced on Monday. Health Ministry spokesperson Hossam Abdel Ghaffar said the agreement supports Egypt's national strategy to attract foreign investment, localise biotechnology industries, and advance scientific research and innovation under the country's Vision 2030 sustainable development framework. The partnership aims to position Egypt as a regional hub for vaccine manufacturing and exports—particularly to African and Arab markets—while ensuring self-sufficiency in critical vaccines and plasma-based products. Sherif El-Fil, CEO of VACSERA, described the deal as a major step toward transferring advanced vaccine manufacturing technologies to Egypt. He said it would secure the domestic supply of safe, effective vaccines and open new export opportunities. El-Fil added that the collaboration will also strengthen VACSERA's capabilities in plasma processing and biopharmaceutical production, reinforcing its role as a key regional player in the vaccine industry. The MoU was signed by Sherif El-Fil for VACSERA, Li Yang, CEO of China's Red Flag, and Ashraf El-Badawy, CEO of UAE's Al Qalaa Investments. © 2025 Daily News Egypt. Provided by SyndiGate Media Inc. (
Zawya
35 minutes ago
- Zawya
Burjeel Holdings reports 129% increase Q2'25 net profit, with accelerated revenue growth
Abu Dhabi, United Arab Emirates: Burjeel Holdings PLC ('Burjeel' or 'the Group'), a leading super-specialty healthcare services provider in MENA listed on the Abu Dhabi Securities Exchange (SYMBOL: BURJEEL; ISIN: AEE01119B224), today announced its financial results in accordance with International Financial Reporting Standards (IFRS) for the three-month and six-month periods ended 30 June 2025. Executing with Focus: Specialized Services, Efficiency, and Expansion Burjeel Holdings accelerated its strategic execution in Q2 2025 with a series of high-impact initiatives that deepened specialization and broadened patient access. The Group expanded its advanced oncology network, integrating Dubai's Advanced Care Oncology Center and opening new Burjeel Cancer Institute (BCI) clinics in Al Ain, Sharjah, and Oman, reinforcing its position as a regional leader in complex cancer care. The UAE's first dedicated cancer pharmacy was also inaugurated, strengthening oncology support infrastructure. In parallel, Burjeel launched a regional mental health platform through its joint venture Alkalma, opening four specialist mental health centers across the UAE and Saudi Arabia. This marked the first phase of a multi-year expansion strategy aimed at addressing rising demand for mental wellness services. In Saudi Arabia, the Group acquired a major physiotherapy facility in Riyadh under the PhysioTherabia platform, adding scale and unlocking turnaround potential through secured government contracts. Investments in operational resilience and access continued with the AED 170 million acquisition of the Medeor Hospital Dubai building, converting long-term lease obligations into ownership and enhancing cost structure flexibility. The Group also expanded its primary care footprint with a new medical center launched on Saadiyat Island, aligning with its growth strategy in high-yield urban catchments. In medical innovation, Burjeel launched DOCKTOUR, a transformative healthcare logistics joint venture with AD Ports Group, aiming to redefine how medical services and infrastructure are delivered to underserved and remote communities. Several specialized centers were introduced, including the region's first Al Muderis Osseointegration Clinic for advanced limb reconstruction, a state-of-the-art Epilepsy Monitoring Unit, and expanded capabilities in rare diseases, hematology, and metabolic research. Additionally, the Group continued its digital transformation with AI-powered diagnostics and led groundbreaking research in microgravity, aiming to transform care for patients with diabetes in space and on Earth. John Sunil, Chief Executive Officer of Burjeel Holdings, said: 'The second quarter delivered exceptionally strong results, with 19% revenue growth driven by a 12% increase in patient footfall and improved yield. EBITDA rose by 59%, accompanied by a margin uplift to 22%. This robust performance significantly strengthened the first-half outcome, underscoring Burjeel Holdings' resilience and long-term sustainable growth. 'These results reflect tangible progress in key operational areas such as physician manpower optimization, formulary management, and cost control, while our strategic focus on super-specialty care is beginning to yield measurable benefits, enhancing both revenue and profitability. We continue to invest in high-value services and next-generation care facilities to support long-term momentum. 'We also advanced key strategic priorities, reinforcing leadership in complex care across oncology, transplants, fertility, mental health, and diagnostics. Our oncology platform is now the UAE's largest private network, featuring new cancer clinics and cell and gene therapy capabilities. The Alkalma mental health platform is scaling regionally, alongside rehabilitation services through over 30 PhysioTherabia centers in Saudi Arabia. Additionally, we introduced the region's first Osseointegration Clinic for cutting-edge prosthetic care. 'In parallel with expanding our network of primary care and medical centers, we deepened partnerships with government and corporate stakeholders and accelerated digital integration through Oracle Health EMR and AI-powered tools. Building on this platform, we entered into pivotal partnerships in oncology, value-based care, diagnostics, and international healthcare innovation, establishing the Group as the healthcare partner of choice. 'Burjeel Holdings is uniquely positioned to capture significant opportunities across the region, supported by rising demand for complex care and a growing population. Our focus remains on converting recent investments into sustained expansion and margin improvement, while maintaining disciplined financial management to support long-term shareholder value. Net profit growth of 129% in the reporting quarter reinforces this trajectory and strengthens the foundation for consistent shareholder returns.' Q2'25: Growth Delivered, Efficiency Embedded Burjeel Holdings delivered strong top-line growth of 18.7% to AED 1,403 million in Q2'25, driven by a 12.1% increase in patient footfall, higher patient yield, and the continued ramp-up of newly launched facilities across the network. Revenue in H1'25 rose 12.2% to AED 2,677 million, with total patient visits reaching 3.4 million. Oncology remained a core growth driver, with revenue rising 36.7% in Q2'25 and 38.1% in H1'25, underpinned by oncology network expansion and improved conversion in surgical and advanced therapies. Other specialties also recorded solid gains in H1'25, including urology (+18%), emergency medicine (+17%), cardiology (+16%), and gastroenterology (+13%). Inpatient footfall rose 17.7% in Q2'25, reflecting strong demand across key specialties and a ramp-up in elective surgeries post-Ramadan. The Group performed 22,930 surgeries, up 18.7%, with momentum concentrated at Burjeel Medical City, Burjeel Specialty Hospital Sharjah, Lifecare Hospital Musaffah and Burjeel Royal Hospital Al Ain. Bed occupancy improved to 69%, up from 65% a year ago, and averaged 69% in H1'25. Inpatient volumes rose 14.6% over the first half. Outpatient footfall grew 12.0% in Q2'25, accelerating from 5.2% in Q1, driven by primary care and physiotherapy centers, along with robust demand in oncology, pediatrics, ophthalmology, and family medicine. Utilization improved to 68%, up from 65% in Q1'25, enabled by optimized hiring and scaling of clinical teams. Leading facilities included Burjeel Medical City, Lifecare Hospital Baniyas, and Burjeel Day Surgery Center Barari. In H1'25, outpatient volumes increased 8.6%. EBITDA rose 59.4% to AED 306 million in Q2'25, fueled by strong revenue growth, enhanced physician productivity, and better performance across recently ramped-up assets. This includes AED 72 million in gains from lease liability derecognition following the Dubai Medeor Hospital acquisition. The EBITDA margin expanded 5.6 p.p. to 21.8%. In H1'25, EBITDA increased 14.2% to AED 487 million, with a margin of 18.2%. Net profit surged 128.9% to AED 148 million in Q2'25, reflecting margin expansion, enhanced operating leverage, and asset optimization. In H1'25, net profit rose 10.6% to AED 187 million. Hospitals Lead Growth, Medical Centers Accelerate The Hospitals segment continued to drive Group performance, contributing 89% of total revenue in Q2'25. Revenue grew 17.3% to AED 1,245 million, supported by strong growth in patient volumes and sustained demand for complex care services. Segment EBITDA rose by 40.6%, led by strong performance across key hospitals, including Burjeel Medical City, Burjeel Hospital Abu Dhabi, Burjeel Day Surgery Center Barari and Burjeel Royal Hospital Al Ain. The Medical Centers segment also delivered exceptional growth, with Q2'25 revenue rising 36.8% to AED 121 million. This was driven by the successful ramp-up of over 45 new centers across the UAE and Saudi Arabia, expanding access to high-quality outpatient and physiotherapy services. In H1'25, Medical Centers revenue increased 26.7% to AED 229 million, reflecting the Group's strong momentum in scaling primary care. BMC: Scaling Patient Base & Driving Efficiency Gains Burjeel Medical City (BMC), the Group's flagship facility, remained a key growth engine, achieved 14.7% growth in revenue to AED 333 million, driven by a 30.4% increase in patient volumes. This performance was underpinned by a higher outpatient share, strong oncology momentum, and robust post-Ramadan demand for minimally invasive and elective procedures. Bed occupancy improved to 68%, underscoring stronger inpatient utilization. Revenue from BMC in H1'25 increased 13.0% to AED 648 million. BMC EBITDA rose 21.3% to AED 59 million in Q2'25, with the EBITDA margin improving to 17.6%. In H1'25, EBITDA grew 20.8% YoY to AED 112 million, with margin expansion of 1.1 p.p. to 17.3%. Profitability growth was supported by scale efficiencies and continued investment in super-specialty services. BMC's performance reinforces its strategic role as the Group's key platform for complex care and future value creation. Disciplined Leverage with Strong Cash Generation Operating cash flow increased 8.1% YoY in H1'25, driven by improved operational performance and disciplined working capital management. Maintenance CAPEX remained in line with guidance, while Growth CAPEX totaled AED 403 million, driven by strategic M&A activities and ongoing network expansion. Free cash flow (FCF)1 conversion improved to 54% in H1'25. The Group's net debt / pre-IFRS 16 LTM EBITDA2 stood at 1.8x as of 30 June 2025, reflecting the acquisition of the Dubai hospital building. This strategic transaction enhanced asset ownership while optimizing the Group's cost structure. The Group maintains a strong and flexible balance sheet, enabling continued investment in growth opportunities. With no contingent off-balance sheet liabilities, management remains focused on optimizing capital structure through debt reduction, refinancing, and tenure extension. Dividend Policy Burjeel Holdings is committed to delivering value to stakeholders while ensuring alignment with strategic growth plans. The Group maintains a dividend policy with a payout range of 40–70% of net income, depending on investment needs for expansion. In May 2025, the Group declared a full-year dividend of AED 170 million for FY2024, representing 47% of net profit. This reflects strong profitability and a balanced approach to rewarding shareholders while supporting long-term growth. About Burjeel Holdings Founded in 2007, Burjeel Holdings is a leading super-specialty healthcare services provider in the UAE and Oman, and it operates a growing specialized healthcare segment in Saudi Arabia. The Group operates an integrated and multi-brand healthcare ecosystem across primary, secondary, tertiary, and quaternary medical care, ensuring complex care delivery to patients across all socioeconomic groups. Its network comprises 112 assets across the UAE, Oman, and Saudi Arabia, including 20 hospitals, 37 medical centers, 30 physiotherapy and wellness centers, 15 pharmacies, and 10 other allied services. Burjeel Holdings' brands include Burjeel, Medeor, LLH, Lifecare, PhysioTherabia, Alkalma, and Tajmeel.
The National
3 hours ago
- The National
From stage to hospital bed: Gaza dabke dancer shot in head while collecting food
Performing on stage brought Ahmed Abo El Khair immense joy. Ever since he was 10, he had been passionate about dabke, the Palestinian folk dance recognised by Unesco as an intangible cultural heritage. Ahmed was a proud and active member of a dabke troupe in Gaza, performing regularly in public. But after being shot in the head while collecting aid at a distribution centre, he was forced off the stage and into a hospital bed. The university student, 20, who was known and loved for his bubbly personality, now lies helpless and frail, staring into the ceiling, almost in disbelief at his current state. The smile on his face and spark in his eyes have vanished. His visible ribs are a testament to his malnutrition. Without proper food and medical treatment, Ahmed cannot recover, his family says. After weeks of near-total starvation, all that remains of him is skin and bones. 'Doctors tell us Ahmed needs proper nutrition to recover, and for his memory to get better, as he has some memory loss, but what can I feed him when there's no food?", his mother, Rana Abo El Khair, told The National. The young Gazan had ventured to an aid centre run by the US-backed Gaza Humanitarian Foundation in Netzarim to secure food for his family, when he was shot in the head. With deteriorating health centres, the bullet remains lodged in his skull, causing a fracture and internal bleeding. The GHF has faced global criticism and condemnation for its food delivery system. Since May, at least 1,373 Palestinians have been killed while seeking food; 859 in the vicinity of the GHF sites and 514 along the routes of food convoys, the UN said last week. He had made the perilous trip in desperation, amid severe food shortages in the enclave. Aid organisations, human rights groups and a global hunger monitor have warned of mass starvation and famine spreading in Gaza, forcing Palestinians to risk their lives for the smallest amounts of food. Although Ahmed miraculously survived, his condition has deteriorated under Israel's blockade of Gaza. His life has been turned upside down. 'Every passing day, his situation gets worse,' his father, Iyad Abo El Khair, told The National. At least 193 people have now died of starvation – 96 of them children – under Israel 's blockade of the coastal territory, according to Gaza's Health Ministry. International efforts have included food being dropped from the air and aid supplies from the UAE and Jordan, but starvation is increasingly being used as a weapon of war in Gaza, according to the UN. The agency's secretary general Antonio Guterres has described the search for food in the enclave as a ' death sentence '. 'He loved food the most, he loved kaak and maftoul [Palestinian food], and he told me to prepare these foods for him once he got back from the aid centre,' Ahmed's mother said. Instead, his mother received a call at 3am to say her son had been injured. Ahmed was immediately admitted into the intensive care unit and later taken into surgery. Gaza's health sector has been significantly crippled by Israeli attacks and bombardment. UN reports have detailed Israel's deliberate and widespread attacking of Gaza's medical sector and medical staff. 'It was shocking to see my son like this, I have no words to describe it,' his mother said. Despite his circumstances, Ahmed has one word on his lips at all times: 'Alhamdulillah', or thank God, his sister, Doha Abo El Khair, told The National. 'Ahmed loved his life, he was happy, he was content, but he also had plans to travel and study abroad after working hard in school,' his sister said. 'But now his future has gone to waste because of his situation,' she added.
